Date	Period	Revenue/Estimate	Earnings Call
Jul 24, 2025	2025/Q2	-- / 328.400B	--
Apr 24, 2025	2025/Q1	-- / 260.850B	--
Jan 30, 2025	2024/Q4	302.111B / 290.332B	--
Oct 25, 2024	2024/Q3	315.700B / 280.871B	--
Jul 25, 2024	2024/Q2	315.911B / 276.349B	--

DatePeriodRevenue/EstimateEarnings Call

Jul 24, 20252025/Q2-- / 328.400B--

Apr 24, 20252025/Q1-- / 260.850B--

Jan 30, 20252024/Q4302.111B / 290.332B--

Oct 25, 20242024/Q3315.700B / 280.871B--

Jul 25, 20242024/Q2315.911B / 276.349B--

Unlock Free Earnings Estimates

Open Account

Chugai Pharmaceutical: Notice regarding dividends from surplus

Jan 30 03:00 ET

Chugai Pharmaceutical: Consolidated financial results for the fiscal year ending 2024/12 [IFRS] supplementary materials

Jan 30 03:00 ET

Chugai Pharmaceutical: Summary of financial results for the fiscal year ending 2024/12 [IFRS] (consolidated)

Jan 30 03:00 ET

Chugai Pharmaceutical: About F Hoffman La Roche's 2024 financial results announcement

Jan 30 01:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Mar 5, 2025

Buy

No Data